患者报告结局及其在恶性肿瘤中的应用
Patient-Reported Outcomes and Its Application in Cancer
DOI: 10.12677/ACM.2022.1281007, PDF,   
作者: 赵晶晶, 赵 红*:延安大学附属医院肿瘤科,陕西 延安
关键词: 恶性肿瘤患者报告结局综述Cancer Patient-Reported Outcome Review
摘要: 从19世纪起,传统的医学模式已经发生转变,由以往的生物医学模式逐步向生物–心理–社会医学模式转变,人们对健康的定义也逐渐丰富,不仅仅是没有疾病体征,良好的心理状态和完整的社会功能也成为评价个人健康状态的重要标准。在21世纪,进一步强调了患者的参与在疾病治疗过程中的重要作用,提出了“以患者为中心”的医疗模式。这种新的理念意可以调动患者在医疗过程中的参与,更深入了解患者的想法、对医疗过程的态度和诊疗中需求,医护专业人员通过积极有效的应答,进一步增强医患沟通、提高医疗服务质量和患者满意度。关注患者报告结局(Patient-Reported Outcomes, PRO)是新型医学模式下增加患者参与诊疗过程的重要途径。本文综述PRO的概念及其在恶性肿瘤领域的意义和应用,并探讨PRO在临床实践中面临的问题。
Abstract: Since the 19th century, the traditional medical model has changed, from the previous biomedical model to the bio-psychological-social medical model, and people’s definition of health has gradually enriched, not only the absence of signs of disease, a good psychological state and complete social function has also become an important criterion for evaluating the health status of individuals. In the 21st century, the important role of patient participation in the process of disease treatment has been further emphasized, and a “patient-centered” medical model has been proposed. This new concept is intended to mobilize patients to participate in the medical process, and to have a deeper understanding of patients’ thoughts, attitudes toward the medical process, and needs in diagnosis and treatment. Through positive and effective responses, medical professionals can further enhance doctor-patient communication and improve medical services, quality and patient satisfaction. Fo-cusing on Patient-Reported Outcome (PRO) is an important way to increase patient participation in the diagnosis and treatment process under the new medical model. This article reviews the concept of PRO and its significance and application in the field of malignant tumors, and discusses the prob-lems faced by PROs in clinical practice.
文章引用:赵晶晶, 赵红. 患者报告结局及其在恶性肿瘤中的应用[J]. 临床医学进展, 2022, 12(8): 6994-6999. https://doi.org/10.12677/ACM.2022.1281007

参考文献

[1] Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005) Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (Pro) Measures: Report of the Ispor Task Force for Translation and Cultural Adaptation. Value Health, 8, 94-104. [Google Scholar] [CrossRef] [PubMed]
[2] Efficace, F., Gaidano, G. and Lo-Coco, F. (2017) Pa-tient-Reported Outcomes in Hematology: Is It Time to Focus More on Them in Clinical Trials and Hematology Practice? Blood, 130, 859-866. [Google Scholar] [CrossRef] [PubMed]
[3] Strong, L.E. (2015) The Past, Present, and Future of Pa-tient-Reported Outcomes in Oncology. American Society of Clinical Oncology Educational Book, 35, e616-e620. [Google Scholar] [CrossRef
[4] 隆莉芝, 袁玲. 患者报告结局的应用近况及思考[J]. 中国全科医学, 2020, 23(32): 4120-4127.
[5] Catt, S., Starkings, R., Shilling, V. and Fallowfield, L. (2017) Pa-tient-Reported Outcome Measures of the Impact of Cancer on Patients’ Everyday Lives: A Systematic Review. Journal of Cancer Survivorship: Research and Practice, 11, 211-232. [Google Scholar] [CrossRef] [PubMed]
[6] Mokkink, L.B., Prinsen, C.A., Bouter, L.M., Vet, H.C. and Ter-wee, C.B. (2016) The Consensus-Based Standards for the Selection of Health Measurement Instruments (Cosmin) and How to Select an Outcome Measurement Instrument. Brazilian Journal of Physical Therapy, 20, 105-113. [Google Scholar] [CrossRef] [PubMed]
[7] Søreide, K. and Søreide, A.H. (2013) Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer—The Last Clinical Frontier in Surgical Oncology? Frontiers in Oncology, 3, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
[8] Calvert, M., Blazeby, J., Altman, D.G., Revicki, D.A., Moher, D., Brundage, M.D. and CONSORT PRO Group (2013) Reporting of Patient-Reported Outcomes in Randomized Trials: The Consort Pro Extension. JAMA, 309, 814-822. [Google Scholar] [CrossRef] [PubMed]
[9] Valderas, J.M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C.E., Halyard, M.Y., et al. (2008) The Impact of Measuring Patient-Reported Outcomes in Clinical Practice: A System-atic Review of the Literature. Quality of Life Research, 17, 179-193. [Google Scholar] [CrossRef] [PubMed]
[10] Husson, O., De Rooij, B.H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N.K., et al. (2020) The Eortc Qlq-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the “Real-World”: Results from the Population-Based Profiles Registry. The Oncologist, 25, e722-e732. [Google Scholar] [CrossRef] [PubMed]
[11] Araujo, L.H., Baldotto, C.S., Monteiro, M.R., Aguiar, P.N., Andrade, M.C., Longo, C.L., et al. (2021) Patient-Centered Outcomes in Non-Small-Cell Lung Cancer: A Real-World Perspective. Future Oncology, 17, 1721-1733. [Google Scholar] [CrossRef] [PubMed]
[12] Bronserud, M.M., Iachina, M., Green, A., Groenvold, M. and Jakob-sen, E. (2019) Patient Reported Outcome Data as Performance Indicators in Surgically Treated Lung Cancer Patients. Lung Cancer, 130, 143-148. [Google Scholar] [CrossRef] [PubMed]
[13] Arbab, M., Chen, Y.H., Criscitiello, S., Glass, J., Fugazzotto, J.A., Killoran, J.H., et al. (2020) Patient Reported Outcomes in Patients with Head and Neck Cancer Treated with Con-current Chemoradiation with Weekly versus Bolus Cisplatin. Head & Neck, 42, 3670-3677. [Google Scholar] [CrossRef] [PubMed]
[14] Bordoni, R., Ciardiello, F., Von Pawel, J., Cortinovis, D., Karagiannis, T., Ballinger, M., et al. (2018) Patient-Reported Outcomes in Oak: A Phase Iii Study of Atezolizumab versus Docetaxel in Advanced Non-Small-cell Lung Cancer. Clinical Lung Cancer, 19, 441-449.e4. [Google Scholar] [CrossRef] [PubMed]
[15] Cavanna, L., Citterio, C. and Orlandi, E. (2020) Feasibility and Util-ity of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer. Patient Related Outcome Measures, 11, 49-66. [Google Scholar] [CrossRef
[16] Efficace, F., Collins, G.S., Cottone, F., Giesinger, J.M., Sommer, K., Anota, A., et al. (2021) Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Sys-tematic Review and Meta-Analysis. Value Health, 24, 250-267. [Google Scholar] [CrossRef] [PubMed]
[17] Van Der Plas-Krijgsman, W.G., De Boer, A.Z., De Jong, P., Bastiaannet, E., van den Bos, F., Mooijaart, S.P., et al. (2021) Predicting Disease-Related and Patient-Reported Outcomes in Older Patients with Breast Cancer—A Systematic Review. Journal of Geriatric Oncology, 12, 696-704. [Google Scholar] [CrossRef] [PubMed]
[18] Mandelblatt, J.S., Clapp, J.D., Luta, G., Faul, L.A., Tallarico, M.D., McClendon, T.D., et al. (2016) Long-Term Trajectories of Self-Reported Cognitive Function in a Cohort of Older Survivors of Breast Cancer: Calgb 369901 (Alliance). Cancer, 122, 3555-3563. [Google Scholar] [CrossRef] [PubMed]
[19] Coens, C., Pe, M., Dueck, A.C., Sloan, J., Basch, E., Calvert, M., et al. (2020) International Standards for the Analysis of Quality-of-Life and Patient-Reported Outcome Endpoints in Cancer Randomised Controlled Trials: Recommendations of the Sisaqol Consortium. The Lancet Oncology, 21, e83-e96. [Google Scholar] [CrossRef
[20] Takeuchi, E.E., Keding, A., Awad, N., Hof-mann U, Campbell, L.J., Selby, P.J., et al. (2011) Impact of Patient-Reported Outcomes in Oncology: A Longitudinal Analysis of Patient-Physician Communication. Journal of Clinical Oncology, 29, 2910-2917. [Google Scholar] [CrossRef